首页> 美国卫生研究院文献>other >In Vitro and In Vivo Studies for Assessing the Immune Response and Protection-Inducing Ability Conferred by Fasciola hepatica-Derived Synthetic Peptides Containing B- and T-Cell Epitopes
【2h】

In Vitro and In Vivo Studies for Assessing the Immune Response and Protection-Inducing Ability Conferred by Fasciola hepatica-Derived Synthetic Peptides Containing B- and T-Cell Epitopes

机译:评估由Fasciola hepatica衍生的含有B细胞和T细胞表位的合成肽赋予的免疫应答和保护诱导能力的体外和体内研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Fasciolosis is considered the most widespread trematode disease affecting grazing animals around the world; it is currently recognised by the World Health Organisation as an emergent human pathogen. Triclabendazole is still the most effective drug against this disease; however, resistant strains have appeared and developing an effective vaccine against this disease has increasingly become a priority. Several bioinformatics tools were here used for predicting B- and T-cell epitopes according to the available data for Fasciola hepatica protein amino acid sequences. BALB/c mice were immunised with the synthetic peptides by using the ADAD vaccination system and several immune response parameters were measured (antibody titres, cytokine levels, T-cell populations) to evaluate their ability to elicit an immune response. Based on the immunogenicity results so obtained, seven peptides were selected to assess their protection-inducing ability against experimental infection with F. hepatica metacercariae. Twenty-four B- or T-epitope-containing peptides were predicted and chemically synthesised. Immunisation of mice with peptides so-called B1, B2, B5, B6, T14, T15 and T16 induced high levels of total IgG, IgG1 and IgG2a (p<0.05) and a mixed Th1/Th2/Th17/Treg immune response, according to IFN-γ, IL-4, IL-17 and IL-10 levels, accompanied by increased CD62L+ T-cell populations. A high level of protection was obtained in mice vaccinated with peptides B2, B5, B6 and T15 formulated in the ADAD vaccination system with the AA0029 immunomodulator. The bioinformatics approach used in the present study led to the identification of seven peptides as vaccine candidates against the infection caused by Fasciola hepatica (a liver-fluke trematode). However, vaccine efficacy must be evaluated in other host species, including those having veterinary importance.
机译:筋膜病被认为是影响全世界放牧动物的最广泛的吸虫病。目前,它已被世界卫生组织确认为一种新兴的人类病原体。曲卡苯达唑仍然是抵抗这种疾病的最有效药物。然而,已经出现了抗药性菌株,开发针对这种疾病的有效疫苗已日益成为当务之急。根据可获得的Fasciola hepatica肝蛋白氨基酸序列的数据,几种生物信息学工具已用于预测B细胞和T细胞表位。通过使用ADAD疫苗接种系统,用合成肽对BALB / c小鼠进行免疫,并测量了几种免疫应答参数(抗体滴度,细胞因子水平,T细胞群体)以评估其引发免疫应答的能力。基于如此获得的免疫原性结果,选择了七种肽以评估其对实验性感染马卡氏乳杆菌的保护诱导能力。预测并化学合成了二十四个含B或T表位的肽。根据所谓的B1,B2,B5,B6,T14,T15和T16肽对小鼠进行免疫,可诱导高水平的总IgG,IgG1和IgG2a(p <0.05)以及混合的Th1 / Th2 / Th17 / Treg免疫反应。 IFN-γ,IL-4,IL-17和IL-10水平升高,伴随CD62L + T细胞数量增加。在接种了带有AA0029免疫调节剂的ADAD疫苗接种系统中配制的B2,B5,B6和T15肽的小鼠中获得了高水平的保护。在本研究中使用的生物信息学方法导致鉴定了七个肽作为候选疫苗,以对抗由肝片状Fasciola(肝吸虫性线虫)引起的感染。但是,必须在其他宿主物种中评估疫苗功效,包括具有兽医重要性的物种。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号